|
Volumn 13, Issue 2, 2006, Pages 98-101
|
Prospective analysis of office-based hysteroscopic sterilization
|
Author keywords
Essure; Hysteroscopy; Office; Sterilization
|
Indexed keywords
NONSTEROID ANTIINFLAMMATORY AGENT;
ADULT;
ARTICLE;
BODY MASS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
DEVICE;
FEMALE;
FOLLOW UP;
HISPANIC;
HUMAN;
HYSTEROSALPINGOGRAPHY;
HYSTEROSCOPY;
LONGITUDINAL STUDY;
OUTPATIENT;
PEROPERATIVE COMPLICATION;
POSTOPERATIVE COMPLICATION;
PROSPECTIVE STUDY;
UTERINE TUBE OCCLUSION;
UTERINE TUBE STERILIZATION;
ADULT;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYSTEROSCOPES;
HYSTEROSCOPY;
INCIDENCE;
LONGITUDINAL STUDIES;
NEW YORK CITY;
OUTPATIENT CLINICS, HOSPITAL;
PROSPECTIVE STUDIES;
RISK ASSESSMENT;
STERILIZATION, REPRODUCTIVE;
SURGICAL PROCEDURES, MINIMALLY INVASIVE;
TREATMENT OUTCOME;
|
EID: 33644750458
PISSN: 15534650
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jmig.2005.11.010 Document Type: Article |
Times cited : (63)
|
References (6)
|